Overview

Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb